In this event organized by ELPA with the title ‘The COMBAT-trial: A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome.’ experts from DECISION explained the upcoming clinical trial to patient representatives. They discussed the recruitment process and what it means from an ethical perspective. Great interest was shown in the question how patient representatives and clinicians can work together to facilitate recruitment for this trial.